HS

Hetal Samir Shah

Active Director Director DIN 06724521
DIN 06724521 First appointment Aug 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value •••• Premium profile

About Hetal Samir Shah

Data last updated:

Hetal Samir Shah is a Director at Avi Pharma Private Limited (since 2017). The company operates in Trading. Avi Pharma Private Limited reported revenue of ₹89.4 Lakh (FY 2020).

DIN 06724521
Primary Designation Director
Industry Trading
First Appointment 05 Aug 2017
Oldest Company Age 18 yrs
Largest company Avi Pharma Private Limited · ₹89.4 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avi Pharma Private Limited U51397UP2007PTC034200
Director05 Aug 20172007₹89.4 Lakh (FY 2020)Active

Board colleagues of Hetal Samir Shah

NameDINCompanyDesignation
Samirkumar Gunavantilal Shah02753328Avi Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avi Pharma Private Limited
Premium access

Shareholding and investment profile for Hetal Samir Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hetal Samir Shah

Hetal Samir Shah currently holds 1 directorship: Avi Pharma Private Limited (Director, since 05 Aug 2017, revenue ₹89.4 Lakh (FY 2020)).

Hetal Samir Shah was first appointed on 05 Aug 2017 as Director at Avi Pharma Private Limited.

The current boards of Hetal Samir Shah's companies include Samirkumar Gunavantilal Shah (Avi Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available